Suggestions
Julie M. Johnson
Executive Leadership Coach and author
Julie Yoo, also known as Julie Johnson, is a distinguished figure in the realm of executive coaching, with a focus on leadership, organizational dynamics, and emotional intelligence. Her expertise lies in guiding leaders through challenges related to self-management, conflict resolution, and coalition building, helping them avoid common pitfalls and progress in their careers. Julie is renowned for her adeptness in assisting executives in navigating the complex political landscape at the C-Suite level, leading to enhanced business outcomes for prominent global organizations such as BlackRock, Bloomberg, Deloitte, and many more. As a guest lecturer at prestigious institutions like Harvard Business School and Yale School of Management, Julie shares her valuable insights and experiences with future business leaders. Prior to establishing her own coaching business, Julie held leadership roles in human resources at renowned firms like Merrill Lynch and Kraft, in addition to serving in academic institutions such as Stanford Law School. Her published works include articles in the Harvard Business Review and books like 'The Female Vision: Women’s Real Power at Work'. Julie is actively involved in various boards and organizations, such as the Norwalk Community College Foundation and the International Women's Forum, contributing her expertise and insights to a diverse range of initiatives. With a diverse educational background including an MBA from Harvard Business School, an MA in Social Psychology, and Counseling from Southern Methodist University, and a BA in Liberal Arts from Carnegie Mellon University, Julie Yoo brings a wealth of knowledge and experience to her coaching practice.
Highlights
There’s a massive opportunity for AI to completely leapfrog in healthcare.
In Kenya, mobile finance emerged because there was no traditional banking system to work around or through.
Medicaid's infrastructure is so dated that it effectively functions like "no infrastructure" for the people trying to use it most - many of whom are mobile-first today.
Great chat with @singareddynm of @hifortunahealth and @flottobrasil of @CedarNY about what could emerge when you leapfrog the broken system entirely and build something better with AI.
Awesome discussions during my visit to DC this week around policy reforms to promote builders and healthy competitive markets:
⏺️ Payment paradigms for AI-based care models - how can we leapfrog the ills of our current reimbursement system and develop new ways to pay for services in a world of more AI-enabled labor abundance and consumer-directed spend (more to come on this!)
⏺️ HTI-5 - unleashing more market-driven competition in HCIT; for all of the vilification of payors and PBMs, those markets are way more competitive than certain HCIT markets!
⏺️ Interoperability in an AI context - as AI becomes a new site of care, the center of gravity of healthcare data is rapidly moving beyond just traditional medical records, and consumer-directed health engagement through AI apps is breaking the context under which legacy data sharing rules were defined.
⏺️ Affordability of big ticket therapies - novel CGT financing strategies, much of which could ultimately be generalized to other high-cost interventions with long ROI time horizons
⏺️ Healthtech infrastructure - are there ways the government can incentive the development of modern tech utilities enabling more real-time transactions
I’ve always viewed healthcare as an industry where (de)regulation can be a catalyst for category creation 👇, and this era is no different. Great to see how motivated DC leaders are to stay apprised of the work of healthtech builders across the country, and to use those insights to inform how our policy frameworks need to evolve to contemplate all the ways by which technology can benefit our healthcare system!

